SVCP
AMPH icon

Silicon Valley Capital Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History

Silicon Valley Capital Partners’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-229
Closed -$8.5K – 251
2024
Q4 		$8.5K Hold
229
– – ﹤0.01% 265
2024
Q3 		$11.1K Hold
229
– – ﹤0.01% 242
2024
Q2 		$9.16K Hold
229
– – ﹤0.01% 249
2024
Q1 		$10.1K Hold
229
– – ﹤0.01% 233
2023
Q4 		$14.2K Hold
229
– – ﹤0.01% 220
2023
Q3 		$10.5K Hold
229
– – ﹤0.01% 189
2023
Q2 		$13.2K Buy
+229
New +$10.2K ﹤0.01% 177

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return